INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 159 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $83,000 | -15.3% | 6 | 0.0% | 0.00% | – |
Q1 2022 | $98,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q4 2021 | $98,000 | +10.1% | 6 | 0.0% | 0.00% | – |
Q3 2021 | $89,000 | -15.2% | 6 | 0.0% | 0.00% | – |
Q2 2021 | $105,000 | -23.9% | 6 | 0.0% | 0.00% | – |
Q1 2021 | $138,000 | -6.8% | 6 | 0.0% | 0.00% | – |
Q4 2020 | $148,000 | -40.6% | 6 | 0.0% | 0.00% | – |
Q3 2020 | $249,000 | -13.2% | 6 | 0.0% | 0.00% | – |
Q2 2020 | $287,000 | -24.1% | 6 | 0.0% | 0.00% | – |
Q1 2020 | $378,000 | -44.2% | 6 | 0.0% | 0.00% | – |
Q4 2019 | $677,000 | -99.7% | 6 | -99.8% | 0.00% | -100.0% |
Q3 2019 | $251,267,000 | -16.6% | 3,787 | 0.0% | 0.04% | -15.1% |
Q2 2019 | $301,247,000 | +44795.2% | 3,787 | +63016.7% | 0.05% | – |
Q1 2019 | $671,000 | +10.9% | 6 | 0.0% | 0.00% | – |
Q4 2018 | $605,000 | -31.6% | 6 | -14.3% | 0.00% | – |
Q3 2018 | $884,000 | +50.3% | 7 | 0.0% | 0.00% | – |
Q2 2018 | $588,000 | +42.0% | 7 | 0.0% | 0.00% | – |
Q1 2018 | $414,000 | -99.3% | 7 | -99.3% | 0.00% | -100.0% |
Q4 2017 | $55,483,000 | -81.2% | 950 | -81.3% | 0.01% | -81.8% |
Q3 2017 | $294,608,000 | +22034.3% | 5,077 | +46054.5% | 0.06% | – |
Q2 2017 | $1,331,000 | – | 11 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |